The 17th BGICC 2025 (Breast, Gynecological and Immuno-oncology International Cancer Conference) is a premier event in the field of oncology, widely recognized as the largest and most prestigious cancer conference in both Africa and the Middle East. Scheduled to take place from January 23-24, 2025, at the Hilton Heliopolis Hotel in Cairo, Egypt, this conference serves as a hub for oncology professionals, researchers, and clinicians to gather and share cutting-edge knowledge and advancements in cancer care and treatment.
The conference will feature a comprehensive agenda that includes high-level lectures, interactive workshops, and specialized courses, providing participants with an opportunity to delve into the latest research and clinical practices in breast cancer, gynecological oncology, and immuno-oncology. The event aims to bridge the gap between scientific discovery and clinical application, offering insights into innovative therapies, emerging treatment protocols, and the evolving landscape of cancer care.
The 17th BGICC 2025 is set to be led by some of the most esteemed experts in oncology. The course will be directed by Prof. Manal El Mahdy from Ain Shams University, with Prof. Rouba Ali-Fehmi from the University of Michigan serving as the course co-director. These renowned experts will guide participants through discussions and sessions on the latest breakthroughs in cancer research and treatment.
By attending BGICC 2025, participants will not only gain valuable knowledge but also network with leaders in the oncology field, share ideas, and collaborate on global efforts to advance cancer treatment and patient care. The conference promises to be an exciting and impactful event that will shape the future of oncology in the region and beyond.
See the Speakers of the Conference Below:
Dilyara Kaidarova
Dr. Dilyara Kaidarova is a distinguished leader in oncology, known for her exceptional contributions to cancer research and treatment. As an active member of the National Academy of Sciences of the Republic of Kazakhstan, she holds prominent positions including Chairman of the Board at the Kazakh Institute of Oncology and Radiology, as well as President of the Kazakhstan Cancer Society.
Her leadership and expertise have been instrumental in advancing the field of oncology not only within Kazakhstan but across Central Asia and beyond. Under her guidance, the Kazakh Institute of Oncology and Radiology has become a hub for cutting-edge research and treatment strategies, improving cancer care in the region. Dr. Kaidarova has played a key role in strengthening international collaborations, driving innovative approaches to cancer prevention, diagnosis, and therapy. Her work continues to influence both clinical practice and oncology research, ensuring better cancer care and outcomes for patients in Kazakhstan and neighboring countries.
Ying Wang
Ying Wang is a distinguished leader in the field of oncology, with a career spanning over two decades. She has made significant contributions to cancer care and research, particularly within Asia. As the Deputy Director of Tianjin Medical University Cancer Institute and Hospital, she has played a pivotal role in advancing cancer treatment and research in the region. Ying Wang has also served as the Executive Associate Editor-in-Chief for Holistic Integrative Oncology, a prestigious journal that highlights the intersection of conventional and integrative cancer therapies.
Her work focuses on developing and promoting innovative integrative treatment strategies, aiming to enhance the quality of life and outcomes for cancer patients. With her vast experience in clinical practice, research, and leadership, Ying Wang has been a driving force in shaping the landscape of oncology in Asia. She is known for her commitment to improving cancer care through a holistic approach that combines traditional methods with emerging therapies, reflecting her dedication to pioneering more comprehensive and effective cancer treatments.
Sara Abbott
Sara Abbott is a highly regarded expert in women’s health pathology, with a particular focus on advancing the understanding and diagnosis of breast and gynecological cancers. Over the course of her career, she has become a key figure in improving cancer diagnostics and treatment outcomes, especially in these crucial areas of women’s health. Her work combines extensive clinical experience with a deep commitment to research, which has led to more precise diagnostic methods and better-targeted treatments.
Through her groundbreaking research, Sara Abbott has contributed significantly to the development of more effective strategies for diagnosing and treating breast and gynecological cancers, ultimately improving patient care. Her expertise has had a lasting impact on the field, and she continues to advocate for innovations that improve the accuracy of diagnoses and lead to better outcomes for women battling these cancers. With a strong focus on precision medicine and cutting-edge research, Dr. Abbott’s contributions have been vital in enhancing the quality of cancer care for women worldwide.
Valerie McCormack
Valerie McCormack is a distinguished researcher at the International Agency for Research on Cancer (IARC), where her impactful work focuses on identifying environmental and lifestyle factors that influence the development of cancer. With a keen emphasis on understanding how various environmental exposures, such as air pollution, chemicals, and dietary habits, contribute to cancer risk, McCormack’s research has been instrumental in advancing cancer prevention strategies globally.
Her contributions have significantly strengthened cancer prevention initiatives, particularly in underserved regions where resources for cancer care and prevention are often limited. By shedding light on modifiable risk factors and raising awareness about the importance of environmental and lifestyle changes, McCormack’s research has helped shape public health policies and improve cancer prevention efforts worldwide. Her work continues to drive essential progress in reducing the global cancer burden and fostering healthier communities.
Partha Basu
Dr. Partha Basu is a highly regarded expert in cancer prevention, with decades of experience in advancing innovative screening programs aimed at reducing the global cancer burden. His work at the International Agency for Research on Cancer (IARC) has been pivotal in improving early detection and developing cost-effective screening strategies, particularly in low- and middle-income countries where access to cancer care is limited.
Dr. Basu has played a significant role in designing and implementing screening initiatives that target cancers with high mortality rates in underserved regions. His efforts focus on making early detection more accessible, cost-efficient, and impactful, helping to identify cancers at a stage when treatment is more likely to be effective. By promoting and advancing these initiatives, Dr. Basu has been instrumental in improving cancer outcomes globally and reducing the healthcare disparities faced by many populations. His ongoing work continues to have a lasting impact on public health, particularly in areas where cancer prevention and detection resources are scarce.
Amal Al Omari
Amal Al Omari is a leading figure in cancer research and scientific leadership in the Middle East. As a prominent oncologist and researcher at the King Hussein Cancer Center (KHCC), she has been at the forefront of efforts to advance cancer treatment, research, and patient care not only in Jordan but across the entire Middle East region.
Her work has had a significant impact on improving cancer care in the region, where she has spearheaded initiatives aimed at enhancing early detection, treatment modalities, and patient outcomes. Her leadership has also helped KHCC become a regional hub for cancer research and innovation, collaborating with international institutions to drive forward the latest advancements in oncology. Dr. Al Omari’s contributions extend beyond clinical practice, as she continues to influence policy, advocate for better cancer care infrastructure, and lead groundbreaking projects that are improving the lives of cancer patients throughout the Middle East and beyond.
David Chapel
Dr. David Chapel is an Assistant Professor in the Department of Pathology at the University of Michigan, where he specializes in Women’s and Perinatal Pathology. He completed his fellowship at the renowned Brigham and Women’s Hospital in Boston, USA, gaining valuable expertise in the field. Dr. Chapel is dedicated to advancing diagnostic pathology, particularly in women’s health, by enhancing the accuracy and efficiency of diagnoses in perinatal and reproductive conditions.
His extensive experience and insights contribute significantly to both academic and clinical advancements in pathology. Dr. Chapel’s work is vital in improving patient care, particularly through better diagnostic methods and treatment strategies for women and perinatal patients. His contributions to the field of pathology position him as a respected figure in advancing medical knowledge and improving healthcare outcomes on a global scale.
Jennifer A. Harvey
Jennifer A. Harvey is a globally recognized expert in breast imaging and cancer detection. With a profound commitment to advancing radiology, she has made significant contributions to the development and enhancement of mammography techniques, ensuring more accurate and efficient breast cancer diagnosis. Her work focuses on improving early detection methods, ultimately leading to better outcomes for patients.
As a leader in the field, Jennifer A. Harvey has been instrumental in shaping the evolution of breast imaging, advocating for the integration of advanced technologies to refine diagnosis and treatment. Her efforts have helped to drive improvements in patient care, contributing to the early identification of breast cancer, which is crucial in improving survival rates and overall prognosis. Through her research and expertise, Harvey continues to push the boundaries of breast cancer detection and treatment.
Meteb Foheidi
Dr. Meteb Foheidi is a distinguished Breast Medical Oncologist and Associate Professor at King Abdul-Aziz Medical City in Saudi Arabia. With a wealth of expertise in oncology, he is renowned for his dedication to advancing cancer research, particularly in the field of breast cancer. His work focuses on improving cancer treatment outcomes and employing innovative approaches to patient care.
Dr. Foheidi has garnered recognition both nationally and internationally for his contributions to oncology. He is highly regarded for his commitment to enhancing the quality of life for cancer patients through personalized treatment strategies and cutting-edge research. As a respected leader in his field, Dr. Foheidi’s participation in this conference promises to offer valuable insights into the future of breast cancer care and global oncology advancements.
Omalkhair Abulkhair
Dr. Omalkhair Abulkair is a leading medical oncologist specializing in breast cancer and gynecologic malignancies. With a strong dedication to advancing cancer research and improving treatment outcomes, she has become a prominent figure in the medical oncology community. Her extensive experience spans both clinical care and cutting-edge research, focusing on enhancing patient care and developing innovative therapies for cancer treatment.
Dr. Abulkhair’s passion for patient-centered care is reflected in her approach to oncology, ensuring that each patient receives the most effective, personalized treatment possible. Her valuable insights and expertise, particularly in the areas of breast cancer and gynecologic malignancies, will significantly contribute to the discussions at the conference.
Sanaa Elsukhun
Prof. Sanaa Elsukhun is a renowned Professor of Medical Oncology at the University of Jordan, widely recognized for her extensive expertise in the field of oncology. With a career dedicated to advancing cancer research and improving treatment outcomes, Prof. Elsukhun has made significant contributions to the understanding and management of various cancers. Her work has had a lasting impact on cancer care, not only in Jordan but also on a global scale.
Prof. Elsukhun’s dedication to oncology research and clinical practice has led to numerous advancements in cancer treatment, with a particular focus on enhancing patient care through innovative therapies. As a respected leader in her field, her participation in the conference will bring invaluable insights into the latest developments in oncology, particularly in the context of improving cancer care and outcomes.
Simona Stolnicu
Prof. Simona Stolnicu is a leading authority in the field of pathology, currently serving as a Professor of Pathology at UMFST Targu Mures in Romania. With a career dedicated to advancing the field of cancer pathology, she has made significant contributions to the understanding of various cancer types, focusing on improving diagnostic techniques. Her extensive research has directly impacted the accuracy and efficiency of cancer diagnostics, enhancing clinical practices and treatment planning.
At this year’s conference, Prof. Stolnicu’s participation will offer attendees the opportunity to gain insights from her vast experience. Her pioneering research continues to drive advancements in cancer diagnosis and treatment. Prof. Stolnicu’s leadership and commitment to elevating the standards of oncology care globally highlight her as a critical figure in the oncology community, and her contributions are shaping the future of cancer pathology.
